Abstract
PGD is presently a safe, accurate, and reliable technique for embryo evaluation with growing value for prevention of genetic disorders. It has been applied for approximately 400 different genetic conditions, with over 99 % accuracy rate in leading PGD centers. Available experience provides the basis for a wider application of PGD not only for genetic diseases currently diagnosed by prenatal diagnosis but also for nontraditional indications for which prenatal diagnosis has not previously been practiced. This includes late-onset and complex disorders with genetic predisposition, such as inherited cancers, familial cardiac diseases, Alzheimer disease/dementia, as well as non-genetic conditions, involving preselection of HLA-matched embryos. This makes PGD a useful tool for improving the access to HLA-compatible stem cell transplantation for congenital and acquired disorders through PGD for HLA matching, already performed in over a thousand cases and resulting in successful HLA-compatible stem cell transplantation. The practical value of PGD is thus no longer limited to the prevention of monogenic disorders but expanded to the treatment of siblings requiring stem cell transplantation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Preimplantation Genetic Diagnosis International Society (PGDIS). Guidelines for good practice in PGD: program requirements and laboratory quality assurance. Reprod Biomed Online. 2008;16:134–47.
ESHRE Preimplantation Genetic Diagnosis (PGD) Consortium. Best practice guidelines for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod. 2011;26:14–46.
Kuliev A. Practical preimplantation genetic diagnosis. New York, NY: Springer; 2012.
Kuliev A, Rechitsky S, Verlinsky O. Prectical preimplantation genetic diagnosis. 3rd ed. London: CRS Press/Taylor and Franis; 2014.
Kuliev AM. Expanding indications for preimplantation genetic diagnosis. Expert Rev Obstet Gynecol. 2011;6:599–607.
Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA. 2001;285:3130–3.
Verlinsky Y, Rechitsky S, Sharapova T, Morris R, Tharanissi M, Kuliev A. Preimplantation HLA typing. JAMA. 2004;291:2079–208.
Rechitsky S, Verlinsky O, Chistokhina A, et al. Preimplantation genetic diagnosis for cancer predisposition. Reprod BioMed Online. 2002;4:148–55.
Verlinsky Y, Rechitsky S, Verlinsky O, et al. Preimplantation diagnosis for p53 tumor suppressor gene mutations. Reprod BioMed Online. 2001;2:102–5.
Holstein M. p53 mutations in human cancers. Science. 1991;253:49–53.
Verlinsky Y, Rechitsky S, Verlinsky O, et al. Preimplantation diagnosis for neurofibromatosis. Reprod BioMed Online. 2002;4:102–5.
Sagi M, Weinberg N, Eilat A, et al. Preimplantation genetic diagnosis for BRCA1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth. Prenat Diagn. 2008;28:292–8.
Moutou C, Gardes N, Nicod JC, Viville S. Preimplantation genetic diagnosis for BRCA1/2–a novel clinical experience. Eur J Obstet Gynecol Reprod Biol. 2009;45:9–13.
Taylor MD, Gokgoz N, Andrulis IL, et al. Familial posterior fossa brain tumors of infancy secondaty to germline mutation of the hSNF5 gene. Am J Hum Genet. 2000;66:1403–6.
Verlinsky Y, Rechitsky S, Verlinsky O, et al. Preimplantation diagnosis for early onset alzheimer disease caused by V717L mutation. JAMA. 2002;287:1018–21.
Goate AM, Chantier-Harlin MC, Mullan M, et al. Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer disease. Nature. 1991;349:704–6.
Murrel J, Hake AM, Quaid KA, Farlow MR, Ghetti B. Early-onset alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol. 2000;57:885–7.
Tupler R, Rogaeva E, Vaula G, et al. A highly informative microsatellite repeat polymorphism in intron 1 of the human amyloid precursor protein (APP) gene. Hum Mol Genet. 1993;2:620–1.
He J, McDermont DA, Song Y, Gilbert F, Kligman I, Basson C. Preimplantation genetic diagnosis of human congenital heart disease and Holt-Oram syndrome. Amer J Med Genet. 2004;126A:93–8.
Kuliev A, Pomerantseva E, Polling D, Verlinsky O, Rechitsky S. PGD for inherited cardiac diseases. Reprod Biomed Online. 2012;24:443–53.
Rechitsky S, Kuliev A, Tur-Kaspa I, Morris R, Verlinsky Y. Preimplantation HLA typing with preimplantation genetic diagnosis. Reprod Biomed Online. 2004;6:488–93.
Kuliev A, Rechitsky S, Verlinsky O, Kalakoutis G, Angastiniotis M, Verlinsky Y. Preimplantation diagnosis and HLA typing for haemoglobin disorders. Reprod BioMed Online. 2005;11:362–70.
Rechitsky S, Kuliev A, Sharapova T, et al. Preimplantation HLA typing with aneuploidy testing. Reprod Biomed Online. 2006;12:81–92.
Kahraman S, Karlilaya G, Sertyel S, Karadayi H, Findicli N, Oncu N. Clinical aspects of preimplantation genetic diagnosis of single gene disorders combined with HLA typing. Reprod Biomed Online. 2004;9:529–32.
Kahraman S, Beyazyurek C, Ekmeksi C, et al. Seven years experience of preimplantation HLA typing: a clinical experience of 327 cycles. Reprod Biomed Online. 2011;23:363–71.
Kahraman S. PGD for HLA: clinical outcomes of HLA compatible transplantation following PGD. Reprod Biomed Online. 2013;26(1):S9–10.
Edwards RG. Ethics of PGD: thoughts on the consequences of typing HLA in embryos. Reprod Biomed Online. 2004;9:222–4.
Conflict of Interest
The authors declare no conflict.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kuliev, A., Rechitsky, S., Verlinsky, O. (2015). Expanding PGD Applications to Nontraditional Genetic and Non-genetic Conditions. In: Sills, E. (eds) Screening the Single Euploid Embryo. Springer, Cham. https://doi.org/10.1007/978-3-319-16892-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-16892-0_15
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16891-3
Online ISBN: 978-3-319-16892-0
eBook Packages: MedicineMedicine (R0)